Sort
30,917 grants matching “tumor microenvironment”
RADIATION-ENHANCED NANOBIOPOLYMER THERAPEUTICS THROUGH THE BLOOD-BRAIN BARRIER
$498,770Gary D Kao · University Of Pennsylvania · RC1 · FY2010 · CA
Role of Metalloproteinases in Mammary Gland Remodeling
$498,641Zena Werb · University Of California, San Francisco · R01 · FY2007 · CA
Role of breast cancer-secreted miRNA in directing a stromal metabolic plasticity
$498,575Shizhen Emily Wang · University Of California, San Diego · R01 · FY2017 · CA
Effector T Cell Trafficking in Ovarian Cancer
$498,552Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
Functions of IKK alpha in Skin Homeostasis and Skin Tumorigenesis
$498,549Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Role of CRTC1-MAML2 in Salivary Mucoepidermoid Carcinoma Pathobiology
$498,468Antonio Luigi Amelio · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · DE
Targeting the innate immune response in HNSCC
$498,386Judith A. Varner · University Of California, San Diego · R01 · FY2023 · DE
Targeting the innate immune response in HNSCC
$498,386Judith A. Varner · University Of California, San Diego · R01 · FY2025 · DE
Targeting the innate immune response in HNSCC
$498,386Judith A. Varner · University Of California, San Diego · R01 · FY2022 · DE
Targeting tumor and T cell DNA methylomes to improve CAR T cell therapies for diffuse midline glioma
$498,337Stephen C Mack · St. Jude Children'S Research Hospital · U01 · FY2025 · CA
Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma
$498,307Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Oncogenic Human Papillomavirus Protein Network
$498,305Peter M Howley · Harvard Medical School · RC1 · FY2010 · CA
The role of Tumor associated macrophages in glioblastoma
$498,283Dolores Hambardzumyan · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · NS
The role of Tumor associated macrophages in glioblastoma
$498,283Dolores Hambardzumyan · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · NS
MDSCs in Ovarian Cancer
$498,257Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
MDSCs in Ovarian Cancer
$498,257Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
MDSCs in Ovarian Cancer
$498,257Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
MDSCs in Ovarian Cancer
$498,257Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens
$498,243Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
The Role of the Amino Acid Hypusine in the Maintenance and Function of Tissue-Resident Macrophages
$498,234Erika L Pearce · Johns Hopkins University · R01 · FY2025 · AI
Protein Kinase Signaling and Cell Cycle Control
$498,230Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2014 · ES
INSIDE-OUT IMMUNOTHERAPY: PREVENTING METASTATIC BREAST CANCER RECURRENCE VIA NANOPARTICLE-DIRECTED MODULATION OF THE TUMOR MICROENVIRONMENT
$498,227Vanderbilt University, The · · FY2016 · Department of the Army
Optimal control models of epithelial-mesenchymal transition for the design of pancreas cancer combination therapy
$498,111Matthew J Lazzara · University Of Virginia · U01 · FY2019 · CA
UCLA Tumor Immunology Institutional Traning Grant
$497,990Michael A Teitell · University Of California Los Angeles · T32 · FY2018 · CA
Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody
$497,984Paul Mathew · Tufts Medical Center · R01 · FY2023 · CA